Actress Dawnn Lewis says there's a good chance that A Different World fans will see her playing Jaleesa Vinson-Taylor again. In a February 2...

The film, which blends new interviews, archival footage and watercolor animation, will drop on the service later this year, and seems likely...

By Brian Stelter, CNN(CNN) — A version of this article first appeared in the Reliable Sources newsletter. You can sign up for free right...

Abigail Slater, who has served as the head of the Justice Department’s Antitrust Division in Donald Trump’s second term, announced her depar...

Right now, it seems like the hottest scripted shows out there are hailing from the Canadian ice. If Heated Rivalry put ice hockey in the spo...

Sinead Keenan, Caoilfhionn Dunne and Roisin Gallagher play friends who begin to suspect something is suspicious about an old chum's death.

AMC Networks is poised for another payday from The Walking Dead as its current streaming deal with Netflix nears its end. During a conferenc...

EXCLUSIVE: Bestselling author Navessa Allen’s popular dark romance novel Lights Out is set for a television adaptation at Netflix. Hannah Sc...

An investment group is trying to sway Netflix shareholders to reject the WBD deal in favor of Paramount.

Although the novels it's based on are set mainly in China, the "3 Body Problem" TV series has taken things in a more worldwide direction.

Kitty Song Covey and the gang are heading back to Netflix this spring as the ‘To All The Boys I’ve Loved Before’ spin-off returns for its th...

Sky has announced “world-first” plans to bring multiple streaming services together as part of a single subscription.The broadcaster is laun...

With the upcoming release of her new Netflix series, How to Get to Heaven from Belfast, Lisa McGee is crafting a whole new world away from D...

Activist investor and Warner Bros. Discovery shareholder Ancora Alternatives LLC threatened to vote ‘no’ on the Netflix deal and launch its...

Stakeholder Ancora Capital argues the rival Paramount bid has more cash, Ellison family backing and "a viable path to regulatory approval."